Media Update, page-1795

By all means send it to the company. The big problem with this company is they just cannot do scale. 20-40m is crap when its a cheap product. They need to be able to offer 100’s of millions.
The Moderna HIV vaccination is under clinical trials using the mrna technology google it there is loads of information. After the access bio 20m covid test go if we ever get them, because access bio seem to be only giving a few each month, and why wouldn’t they as they can reap a higher margin selling direct.
At1 should have taken the $10-15m on the use it or pay deal they did. But they took $2.2m and a dubious supply arrangement for covid tests. Covid is a non event pretty much in a month. Just like pre pandemic flu.
Clearly management is inept at commercial business arrangements. All their deals fall through and costs rise (JK 100% increase in salary) and losses accumulate. The CFO bangs on about growing revenue but costs out grow the growth in revenue.
In summary they dont make money and clearly show no line of sight that they can make money.
about time JK does a webinar and lets us ask live questions rather than cherry pick pre loaded questions